Literature DB >> 1494166

Pancytopenia related to azathioprine--an enzyme deficiency caused by a common genetic polymorphism: a review.

A Anstey1, L Lennard, S C Mayou, J D Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1494166      PMCID： PMC1293765          DOI： 10.1177/014107689208501213

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  36 in total

1.  6-Mercaptopurine-related leucopenia and in vivo xanthine oxidase activity.

Authors:  P J Goadsby; R O Day; Y L Kwan; J Miners; D J Birkett
Journal:  Lancet       Date:  1986-10-11       Impact factor: 79.321

2.  Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis.

Authors:  R Hohlfeld; M Michels; K Heininger; U Besinger; K V Toyka
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

3.  National Cooperative Crohn's Disease Study: adverse reactions to study drugs.

Authors:  J W Singleton; D H Law; M L Kelley; H S Mekhjian; R A Sturdevant
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

4.  Long-term maintenance therapy with azathioprine in systemic lupus erythematosus.

Authors:  E Ginzler; E Sharon; H Diamond; D Kaplan
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

5.  Azathioprine-induced pancytopenia. Occurrence in two patients with connective-tissue diseases.

Authors:  B R Bacon; W H Treuhaft; A M Goodman
Journal:  Arch Intern Med       Date:  1981-02

6.  Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.

Authors:  R M Weinshilboum; F A Raymond; P A Pazmiño
Journal:  Clin Chim Acta       Date:  1978-05-02       Impact factor: 3.786

7.  Pancytopenia in systemic lupus erythematosus related to azathioprine.

Authors:  J C Nossent; A J Swaak
Journal:  J Intern Med       Date:  1990-01       Impact factor: 8.989

8.  Human liver xanthine oxidase: nature and extent of individual variation.

Authors:  R Guerciolini; C Szumlanski; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1991-12       Impact factor: 6.875

9.  Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism.

Authors:  L Lennard; J A Van Loon; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1989-08       Impact factor: 6.875

10.  Pancytopenia related to azathioprine in rheumatoid arthritis.

Authors:  M E Jeurissen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103
View more
  21 in total

Review 1.  Clinical pharmacology of inflammatory bowel disease therapies.

Authors:  W J Sandborn; W A Faubion
Journal:  Curr Gastroenterol Rep       Date:  2000-12

2.  Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.

Authors:  Bhairavi Balram; Joshua Lubov; Yves Theoret; Waqqas Afif; Alain Bitton; Gary Wild; Peter L Lakatos; Talat Bessissow
Journal:  Dig Dis Sci       Date:  2020-06-26       Impact factor: 3.199

3.  TPMT in the treatment of inflammatory bowel disease with azathioprine.

Authors:  A Qasim; J Seery; M Buckley; C O Morain
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

4.  Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine.

Authors:  T Dervieux; Y Médard; V Baudouin; A Maisin; D Zhang; F Broly; C Loirat; E Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

5.  Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase.

Authors:  M Konstantopoulou; A Belgi; K D Griffiths; J R C Seale; A W Macfarlane
Journal:  BMJ       Date:  2005-02-12

6.  Dermatology in the postgenomic era: harnessing human variation for personalized medicine.

Authors:  Anthony E Oro
Journal:  Arch Dermatol       Date:  2008-03

7.  Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine.

Authors:  Vishal N Patel; David C Kaelber
Journal:  J Biomed Inform       Date:  2013-10-28       Impact factor: 6.317

Review 8.  Neutropenia in the Elderly: A Rheumatology Perspective.

Authors:  Su-Ann Yeoh; Christine Fox; Richard Hull
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

Review 9.  Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.

Authors:  A Anstey
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

10.  Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity.

Authors:  B Klemetsdal; B Straume; R Lysaa; T Giverhaug; J Aarbakke
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.